Hims Hers Health is trading 4.16% up now at $31.07 as U.S. equities rally, with the Nasdaq Composite up 1.36% and technology shares leading gains.
- Nvidia’s stronger outlook has reinforced risk-on buying across growth stocks.
- The move appears to be a market-driven rebound rather than fresh company-specific news.
- Investors continue monitoring Visa’s Acquirer Monitoring Program action, which could impose nearly $75,000 in September surcharges tied to elevated disputes.